We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

177 hedge funds and large institutions have $2.92B invested in ANACOR PHARMACEUTICALS INC COM in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 67 increasing their positions, 59 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

421% more call options, than puts

Call options by funds: $165M | Put options by funds: $31.7M

105% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 20

29% more capital invested

Capital invested by funds: $2.27B → $2.92B (+$653M)

14% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 59

13% more funds holding

Funds holding: 157 → 177 (+20)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

Holders
177
Holders Change
+20
Holders Change %
+12.74%
% of All Funds
4.77%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
41
Increased
67
Reduced
59
Closed
20
Calls
$165M
Puts
$31.7M
Net Calls
+$133M
Net Calls Change
+$91.7M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$79.4M
2
JHIU
Janus Henderson Investors US
Colorado
+$77.8M
3
Invesco
Invesco
Georgia
+$14.2M
4
NCGI
Next Century Growth Investors
Minnesota
+$13.6M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$10.7M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$48M
2
BBA
Baker Bros. Advisors
New York
-$38M
3
KCM
Kingdon Capital Management
New York
-$29.6M
4
FCM
Farallon Capital Management
California
-$26.2M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$22M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
26
Century Capital Management
Massachusetts
$18.7M -$15.8M -241,586 -50%
Deutsche Bank
27
Deutsche Bank
Germany
$17.8M -$4.06M -61,892 -21%
QF
28
QVT Financial
New York
$15.3M -$5.65M -86,137 -30%
Morgan Stanley
29
Morgan Stanley
New York
$14.9M +$1.27M +19,355 +11%
TCIM
30
TIAA CREF Investment Management
New York
$14.9M +$2.58M +39,346 +26%
CS
31
Credit Suisse
Switzerland
$14.3M +$1.8M +27,381 +17%
Loomis, Sayles & Company
32
Loomis, Sayles & Company
Massachusetts
$13.8M -$7.04M -107,359 -38%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$13.6M +$5.09M +77,591 +79%
HH
34
HWG Holdings
Texas
$13.4M +$6.99M +106,638 +153%
BIM
35
Bogle Investment Management
Massachusetts
$13.3M -$3.74M -57,017 -25%
Citadel Advisors
36
Citadel Advisors
Florida
$13M +$6.44M +98,278 +141%
RA
37
Royce & Associates
New York
$12.3M -$8.2M -125,000 -44%
JP Morgan Chase
38
JP Morgan Chase
New York
$12.3M +$7.88M +120,169 +311%
Asset Management One
39
Asset Management One
Japan
$12M +$6.81M +103,870 +194%
BIM
40
BlackRock Investment Management
Delaware
$11.6M +$2.24M +34,175 +29%
LOAMU
41
Lombard Odier Asset Management (USA)
New York
$11.6M -$5.26M -80,223 -35%
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
$10.8M +$3.45M +52,600 +60%
OAM
43
Oxford Asset Management
United Kingdom
$10.6M -$10.8M -164,836 -55%
Lord, Abbett & Co
44
Lord, Abbett & Co
New Jersey
$10.3M -$5.32M -81,081 -38%
Two Sigma Advisers
45
Two Sigma Advisers
New York
$10.3M +$1.95M +29,800 +29%
O
46
OrbiMed
New York
$9.99M +$8.46M +129,000 New
Marshall Wace
47
Marshall Wace
United Kingdom
$9.79M -$9.31M -141,991 -53%
Charles Schwab
48
Charles Schwab
California
$9.77M -$10.6K -161 -0.1%
BG
49
BlackRock Group
United Kingdom
$9.53M +$730K +11,129 +10%
UBS Group
50
UBS Group
Switzerland
$9.45M -$280K -4,266 -3%
1
2
3 4 5

ANAC Hedge Fund Activity: Q2 2015 in Review

177 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q2 2015, worth a combined $2.92B — up 29% from $2.27B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new ANAC positions and 20 closed out — a net gain of 21 holders — while 67 added to existing stakes and 59 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $79.4M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $48M sold.

  • 177 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q2 2015, up from 157 in Q1 2015.
  • Funds reported $2.92B of ANACOR PHARMACEUTICALS INC COM stock for Q2 2015, up 29% quarter-over-quarter.
  • 41 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q2 2015 and 20 closed out, a net change of +21 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q2 2015 was Fidelity Investments, an estimated $79.4M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q2 2015 was Consonance Capital Management, an estimated $48M sold.

Based on aggregated 13F filings for Q2 2015.